Eriksson Hanna, Fereshtehnejad Seyed-Mohammad, Falahati Farshad, Farahmand Bahman, Religa Dorota, Eriksdotter Maria
Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Alzheimer's Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
J Alzheimers Dis. 2014;41(2):411-9. doi: 10.3233/JAD-132273.
Due to age of onset, Alzheimer's disease (AD) is divided into early onset (EOAD) or late onset (LOAD), but emerging data also suggests that the underlying pathology may be different. Whether differences in clinical care exist is less well investigated.
To evaluate whether there are differences in demographics, diagnostic work-up, and pharmacological treatment between EOAD and LOAD.
Data on patients with newly diagnosed EOAD (n = 453) and LOAD (n = 4599) was obtained from the Swedish dementia registry (SveDem). Logistic regression models were used to adjust the comparisons for the baseline confounders including gender, cognitive decline, and co-morbidity.
The majority of EOAD and LOAD were in the mild stage of the disease when diagnosed. The majority of patients with EOAD went through an extended diagnostic work-up including more technical investigations as well as assessments by neuropsychologists and speech therapists than patients with LOAD. EOAD patients were treated with overall fewer medications but obtained treatment with cholinesterase inhibitors to a higher extent than those with LOAD, while there were no differences between the groups in antidepressant and antipsychotics use.
There are differences between EOAD and LOAD in demographics, diagnostic work-up, and pharmacological treatment. Based on our findings, an extensive work-up should be recommended when EOAD is suspected.
由于发病年龄,阿尔茨海默病(AD)分为早发型(EOAD)或晚发型(LOAD),但新出现的数据也表明其潜在病理可能不同。临床护理方面是否存在差异的研究较少。
评估早发型AD和晚发型AD在人口统计学、诊断检查及药物治疗方面是否存在差异。
从瑞典痴呆症登记处(SveDem)获取新诊断的早发型AD患者(n = 453)和晚发型AD患者(n = 4599)的数据。采用逻辑回归模型对包括性别、认知衰退和合并症在内的基线混杂因素进行比较调整。
大多数早发型AD和晚发型AD患者在确诊时处于疾病的轻度阶段。与晚发型AD患者相比,大多数早发型AD患者接受了更广泛的诊断检查,包括更多的技术检查以及神经心理学家和言语治疗师的评估。早发型AD患者总体用药较少,但接受胆碱酯酶抑制剂治疗的比例高于晚发型AD患者,而两组在使用抗抑郁药和抗精神病药方面没有差异。
早发型AD和晚发型AD在人口统计学、诊断检查和药物治疗方面存在差异。根据我们的研究结果,当怀疑为早发型AD时,建议进行全面的检查。